Hasbro has responded to the latest batch of questions! Read on for the info!
- Originally, Michael Bay had said Transformers 3 would debut in theaters in 2012. This past week he said the date had been moved up one year to 2011. Knowing that you can’t get into specifics of what you are doing, has this put additional pressure on your team to get movie product on shelves a year earlier or has there always been a plan in place since the release date was never set in stone by the studio until now?
Editor’s Note: This was a difficult question to be answered, and Hasbro has unfortunately been unable to get a suitable answer for ASM. Don’t blame them, blame Phil for asking it. - In the Revenge of the Fallen line, the toy called “Scalpel” was called “Doctor” in the movie. Does this mean Hasbro have “real” Transformer names for “Reedman” (the mantis-like creature who steals NEST’s AllSpark shard) or Alice, is this a trademark issue raising its head, or is it a case of the movie name being changed too late for the toy name/packaging to be altered?
In the film many names are used as descriptors “doctor” that describe
jobs/roles of the character to help the audience understand who these
characters are. As we felt that it was important to make sure that we
give every robot a robot name and a role, thus the name “Scalpel” for the
doctor. - Based on past releases, it seems to be possible to repair older molds to restore detail lost with repeated use. Specifically, the G1 Jazz mold appears to have had its face detail corrected between the 2003 U.S. reissue and the 2004 release of the mold as Ricochet. Are there limits to how much damage can be repaired, or is it just a matter of whether it’s economically feasible to repair a mold?
The easy answer to your question below is yes, there are limits to how
much maintenance we can do to existing molds when repairs are necessary
just as there are with any type of manufacturing process. As we reach
that point and make decisions on how to proceed, we deal with each of
these situations on a case by case basis.